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ABSTRACT
Immunohistochemical expression of vascular 
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Objective: This study assessed and compared the immunoexpression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) in radicular 
cysts (RCs) and residual radicular cysts (RRCs), relating them to the angiogenic index and 
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were evaluated by immunohistochemistry using anti-VEGF and anti-MMP-9 antibodies. The 
angiogenic index was determined by microvessel count (MVC) using anti-von Willebrand 
factor antibody. Results: The expression of both VEGF and MMP-9 was higher in RCs than 
in RRCs. RCs and RRCs presented strong epithelial expression of VEGF, irrespective of the 
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(p<0.05) and higher number of immunopositive cells for VEGF (p<0.05). There was a 
positive correlation between both MVC (p<0.05) and the quantity of immunopositive cells 
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a positive correlation between the number of immunopositive cells for VEGF and MVC 
(p<0.05). Conclusions: VEGF and MMP-9 might play important roles in the angiogenesis 
in RCs and RRCs. In these lesions, the expression of these molecules and the MVC is 
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epithelial lining of RCs and RRCs might be important for the enlargement of these lesions.
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INTRODUCTION
Periapical lesions occur as a result of the 
immunological response to continuous antigenic 
stimulation from root canals36. As a consequence 
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the epithelial rests of Malassez are stimulated to 
proliferate, which may result in the development of 
radicular cysts (RCs)18,24. If inadvertently left behind 
after the extraction of the involved tooth, RCs are 
named residual radicular cysts (RRCs)21. Although 
RCs and RRCs share similar histopathologic 
characteristics, these lesions may possess different 
biochemical properties, since the focus of stimulus 
is not present in RRCs24.
Recent studies suggest a role for vascular 
endothel ia l  growth factor (VEGF) in the 
pathogenesis of RCs10,16,26 and RRCs26. VEGF is 
a potent proangiogenic cytokine which acts on 
the vasculature by inducing the proliferation, 
differentiation and migration of vascular endothelial 
www.scielo.br/jaos
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cells4,6,32. Additionally, VEGF can induce microvascular 
permeability, leading to extravasation of plasma 
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6,11,32. Thus, 
VEGF might be important for the development and 
evolution of RCs10,16 and RRCs26.
Angiogenesis is the process by which new 
blood vessels are produced by sprouting from pre-
existing vasculature4,11,32, and occurs by a series 
of sequential steps25,34. In response to angiogenic 
stimuli, endothelial cells degrade the basement 
membrane of microvessels by secreting proteolytic 
enzymes, including matrix metalloproteinases 
(MMPs), particularly MMPs-2 and 925,34. The cells then 
migrate through the degraded basement membrane 
and continue to break down the interstitial matrix as 
they move25,34. The endothelium aligns in a bipolar 
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formed hollow sprouts anastomosis with each other 
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Results from studies in several pathologic 
processes have demonstrated the existence of 
an important relationship between VEGF and 
MMP-912,14,17. Hollborn, et al.12 1JK4'
hypoxic expression of MMP-9 may stimulate the 
production and secretion of VEGF under pathologic 
conditions. In addition, Lee, et al.14 (2007) observed 
that intracerebral hemorrhage induced by VEGF is 
associated with increased expression of MMP-9.
Studies investigating the expression of MMP-91,5 
and VEGF10,16,26 in periapical lesions are scarce. To 
the best of our knowledge, there are no studies 
analyzing the expression of both VEGF and MMP-9 
in RCs and RRCs. Therefore, the aim of this study 
was to assess and compare the immunoexpression 
of these molecules in RCs and RRCs, relating them 
to the angiogenic index and the intensity of the 

	
MATERIAL AND METHODS
Thirty tissue specimens, 20 RCs and 10 
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Pathology of the Federal University of Rio Grande 
do Norte (UFRN), Brazil, were randomly selected 
for this study. All RCs were obtained from teeth 
without endodontic treatment. In addition, all 
lesions presented unequivocal cystic cavity lined 
by odontogenic epithelium. The cases were not 
matched for age, sex, or anatomic location. Serial 
5-m-thick and 3-m-thick sections were taken 
from tissue blocks and processed for morphological 
and immunohistochemical studies, respectively. 
The study was approved by the Research Ethics 
Committee of the University of Brasília, Brazil.
Morphological study
Tissue sections were stained with hematoxylin 
and eosin technique. The intensity of the 
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the method proposed by Tsai, et al.33 (2004). Each 
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the inner portion of the specimen and proceeding 
deeper into connective tissue. Thickness of the 
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layers) or hyperplastic (>10 cell layers), according 
to Moreira, et al.22 (2000).
Immunohistochemical methods
Tissue sections were deparaffinized and 
immersed in methanol with 0.3% hydrogen peroxide 
to block endogenous peroxidase activity. The tissue 
sections were then washed in phosphate-buffered-
saline (PBS). Antigen retrieval for antibody anti-
VEGF (C-1 clone; Santa Cruz Biotechnology, Santa 
Cruz, CA, USA) was performed in oven (Trypsin 
pH 7.9, 60 min). Antigen retrieval for antibodies 
anti-MMP-9 (2C3 clone; Novocastra, Newcastle, 
England, UK) and anti-vWF (F8/86 clone; Dako, 
Glostrup, Copenhagen, DEN) was performed in 
steamer (citrate pH 6.0, 30 min). In sequence, the 
tissue sections were incubated with primary mouse 
antibodies anti-VEGF (dilution 1:400, overnight), 
anti-MMP-9 (dilution 1:20, overnight), and anti-
vWF (dilution 1:50, 60 min). The tissue sections 
were then washed twice in PBS and treated with 
streptavidin-biotin-peroxidase complex (Dako) at 
room temperature in order to bind the primary 
antibodies. Peroxidase activity was visualized by 
immersing tissue sections in diaminobenzidine 
(D5637; Sigma Chemical, St. Louis, MO, USA), 
resulting in a brown reaction product. Finally, 
tissue sections were counterstained with Mayer’s 
hematoxylin and coverslipped. Positive controls 
were sections of normal human kidney for VEGF 
and vWF, and sections of periapical granuloma for 
MMP-9. As negative controls, samples were treated 
as above, except that the primary antibody was 
replaced by a solution of bovine serum albumin 
(BSA) in PBS.
Immunostaining assessment and statistical 
analysis
Immunoexpression of VEGF was evaluated 
both in the connective tissue and in the epithelial 
lining of RCs and RRCs. In the connective tissue, a 
quantitative assessment of the immunopositive cells 
was performed, irrespective of the color intensity, 
according to the method proposed by Freitas, et 
al.8 (2005). Tissue sections were examined under 
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counting of the immunopositive cells was performed 
$


The immunoexpression of VEGF in the epithelial 
"%'	'%Z
$
 !
  
 
 
method proposed by Leonardi, et al.16 (2003), the 
%


*+/0$
according to the following scores: 0 – no staining; 
1 – weak, staining in 11-25% of cells; score 2 – 
moderate, staining in 26-75% of cells; 3 – strong, 
staining in more than 76% of cells.
The immunoexpression of MMP-9 was semi-
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The method proposed by Franchi, et al.7 (2002) 
was adapted. Thus, the expression of MMP-9 
was assessed in endothelial cells of vessels with 
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scores: 0 – no staining; 1 – weak, staining in less 
than 10% of vessels; 2 – moderate, staining in 11-
50% of vessels; 3 – strong, staining in more than 
51% of vessels.
Angiogenic index was determined based on the 
number of vessels immunoreactive to anti-vWF 
antibody. Adopting the methodology utilized by 
Freitas, et al.8 (2005), a microvessel count (MVC) 
was performed. Tissue sections were examined 
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The results obtained were submitted to statistical 
analysis. Computations were made using the 
Statistical Package for the Social Sciences (SPSS 
13.0). To analyze the immunoexpression of VEGF 
in the epithelial lining and the expression of MMP-
9 in blood vessels, Mann-Whitney nonparametric 
test was performed. Comparison of the number of 
cells immunoreactive for VEGF in the connective 
tissue and MVC was performed by the Kruskal-
Wallis and Mann-Whitney nonparametric tests. 
Finally, Spearman’s correlation test was performed 
in order to verify possible correlations between the 
variables analyzed. For all tests, a p value <0.05 
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RESULTS
Morphological analysis
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infiltrate grade III, 5 cases (25%) presented 
%B Lesion n %" F25*F75 %	H	&	B U p
VEGF RC 20 590.50 505.75 – 688.75 17.20 66.00 0.135
RRC 10 460.00 256.00 – 618.50 12.10
vWF RC 20 233.00 199.00 – 287.50 17.00 70.00 0.187
RRC 10 199.50 145.50 – 277.75 12.50
MMP-9 RC 20 3.0 2.0 – 3.0 17.30 64.00 0.067
RRC 10 1.0 1.0 – 3.0 11.90
Legend: RC – Radicular cyst; RRC – Residual radicular cyst 
Table 1- Parameters used for the calculation of the Mann-Whitney U test for the evaluation of the expression of vascular 
endothelial growth factor (VEGF), von Willebrand factor (vWF), and matrix metalloproteinase-9 (MMP-9) according to the 
type of lesion 
%B K//M	+ n %" F25*F75 %	H	&	B  p
VEGF Grade Ia 5 373.00 242.00 – 547.50 8.20 6.660 0.036
Grade IIa 8 412.00 245.00 – 636.50 12.88
Grade IIIb 17 611.00 549.50 – 682.50 18.88
vWF Grade Ia 5 173.00 154.00 – 240.00 9.80 9.208 0.010
Grade IIa 8 191.00 139.75 – 220.75 10.00
Grade IIIb 17 257.00 218.50 – 342.50 19.76
MMP-9 Grade I 5 1.0 1.0 – 2.0 8.70 5.492 0.064
Grade II 8 2.50 1.25 – 3.0 15.00
Grade III 17 3.0 2.0 – 3.0 17.74
	
		
	
			
	


Table 2- Parameters used for the calculation of the Kruskal-Wallis (KW) test for the evaluation of the expression of vascular 
endothelial growth factor (VEGF), von Willebrand factor (vWF), and matrix metalloproteinase-9 (MMP-9) according to the 
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Analysis of the epithelial thickness in RCs 
revealed a hyperplastic epithelium in 14 cases 
(70%) and an atrophic epithelium in 6 cases 
(30%). In RRCs, 6 cases (60%) presented an 
atrophic epithelium and 4 cases (40%) showed a 
hyperplastic epithelium.
Figure 1-
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Endothelial cells showing strong immunoreactivity for MMP-9 in a specimen of radicular cyst (SABC method, original 
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Immunohistochemical analysis
The mean number of cells immunopositive for 
VEGF was 565.05 and 443.90 in RCs and RRCs, 
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Analysis of the epithelial expression of VEGF 
disclosed a predominance of strong immunoreactivity 
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relation to the epithelial thickness, there was a 
predominance of strong immunoreactivity (score 3) 
for both cysts with hyperplastic epithelium (Figure 
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(Table 3) (Figure 1d).
The mean number of blood vessels determined 
by MVC was 250.85 in RCs (Figure 1e), and 217.00 
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Analysis of the immunoexpression of MMP-9 in 
the endothelial cells disclosed a predominance of 
strong immunoreactivity (score 3) for RCs (Figure 
1f), and a predominance of weak immunoreactivity 
1$
 4 
  1K4 1& 4 
was a predominance of weak expression (score 1) 
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grade II revealed a predominance of moderate 
to strong expression (score 2-3) of this protease 
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(score 3) of MMP-9 (Table 2). There was no 
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In order to evaluate differences in the MVC 
and in the number of immunopositive cells for 
VEGF according to the expression of MMP-9 in 
endothelial cells, cases showing weak and moderate 
expression of MMP-9 were grouped and compared 
with cases presenting high expression of MMP-
9. Lesions showing high expression of MMP-9 in 
endothelial cells exhibited higher number of both 
%
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*+/0141&4
&

'1\41&4
Spearman’s correlation test disclosed a positive 
correlation between the number of immunopositive 
cells for VEGF (rKK] 4   
the angiogenic index (r33] J4 
	
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correlation between the number of immunopositive 
cells for VEGF and the angiogenic index (r3#]
\4  
 
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	7  
a positive correlation between both number of 
immunopositive cells for VEGF (r3]J4
and angiogenic index (r3\#] J47 
expression of MMP-9 in endothelial cells.
Variable Group n %" F25*F75 %	H	&	B U p
Type of lesion RC 20 3.0 2.0 – 3.0 14.60 82.00 0.360
RRC 10 3.0 2.0 – 3.0 17.30
Epithelial thickness Atrophic 12 3.0 2.0 – 3.0 15.83 104.00 0.845
Hyperplastic 18 3.0 2.0 – 3.0 15.28
Legend: RC – Radicular cyst; RRC – Residual radicular cyst 
Table 3- Parameters used for the calculation of the Mann-Whitney U test for the evaluation of the epithelial expression of 
vascular endothelial growth factor (VEGF) according to the type of lesion and epithelial thickness
%B RZ-	H	%%*( n %" F25*F75 %	H	&	B U p
VEGF Weak/ Moderate 12 335.50 244.00 – 555.25 9.25 33.00 0.001
Strong 18 618.50 546.25 – 671.25 19.67
vWF Weak/ Moderate 12 177.00 153.00 – 241.75 9.67 38.00 0.003
Strong 18 254.50 213.25 – 351.25 19.39
Table 4- Parameters used for the calculation of the Mann-Whitney U test for the evaluation of the expression of vascular 
endothelial growth factor (VEGF) and von Willebrand factor (vWF) according to the expression of matrix metalloproteinase-9 
(MMP-9)
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DISCUSSION
The importance of angiogenesis in the 
development and progression of periapical lesions 
has been highlighted in a number of studies10,16,26. 
VEGF, a dimeric glycoprotein with a selective 
mitogenic effect on vascular endothelial cells4,6,11,32, 
plays several pivotal functions in angiogenesis4,11. 
This proangiogenic cytokine is capable of inducing 
microvascular permeability, leading to extravasation 
of plasma proteins and a predictable sequence of 
proangiogenic stromal changes16. Due to these 
functions, VEGF has been implicated as an important 
factor in granulation tissue development4,11, and 
cyst enlargement30,35.
In the present study, VEGF expression was 
observed both in the connective tissue and in the 
epithelial lining of RCs and RRCs, corroborating 
previous reports10,16,26. In line with other studies10,26, 
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of immunopositive cells for VEGF (p<0.05) and 
a high MVC (p<0.05). Moreover, there was a 
positive correlation between both number of 
immunopositive cells for VEGF (p<0.05) and MVC 
12347  	
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consequently, in angiogenesis itself27. The low level 
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antigenic stimulation24, could be responsible for the 
low expression of VEGF, and consequently low MVC, 
in these lesions.
Graziani, et al.10 (2006) verified a positive 
correlation between the expression of VEGF and 
the microvessel density. Despite using a different 
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the number of immunopositive cells for VEGF 
and the quantity of vessels immunoreactive for 
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mitogenic effect of VEGF on vascular endothelial 
cells described in the literature4,6,11,32.
The epithelium status of the RCs has been 
suggested as a reliable histological parameter 
of biological activity and/or inactivity of cystic 
growth22. On lesions with atrophic epithelium, 
despite the presence of antigens and enzymes able 
to induce immunological responses, epithelium 
proliferation and bone resorption, cyst enlargement 
does not occur22. Immunosuppressor effectors22 or 
apoptotic events19 are supposed to operate in such 
phases, regulating cyst enlargement. In spite of 
those reports, our results revealed a predominance 
of strong epithelial immunoreactivity (score 3) for 
VEGF in RCs, irrespective of the epithelial lining 
thickness. Therefore, the epithelial expression 
of VEGF in RCs might constitute an additional 
mechanism for the enlargement of these lesions, 
maintaining the stimulus for angiogenesis and 
vascular permeability16,26. Results from studies 
on brain tumor cysts30,35 suggest that VEGF might 
enhance accumulation of cyst fluid altogether 
with an increase in oxygen supply boosting the 
development of the cyst35.
The RRCs have been described as lesions 
with lower epithelial proliferative potential, 
in comparison to RCs31. In the present study, 
there was a predominance of strong epithelial 
immunoreactivity (score 3) for VEGF in RRCs, 
$' 
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Thus, in spite of the low proliferative potential 
reported in the literature31, the expression of 
VEGF by the epithelial lining of RRCs might 
contribute with cyst enlargement. Accordingly, 
Muglali, et al.24 1J4 '  $ 

interleukin-1a, monocyte chemotactic protein 
1, and regulated upon activation normal T-cell 
$1+4$	$%
of RRCs, suggesting the existence of a potential for 
expansion in these lesions.
MMP-9 is a proteolytic enzyme that can 
degrade type IV collagen and laminin, major 
components of basement membranes3, and 
thereby allows proteolysis-associated migration of 
endothelial cells12,14. In addition to this proteolytic 
activity, MMP-9 has been involved in activation of 
growth factors and cytokines12,23,34, recruitment of 
endothelial progenitor cells12,34, and generation of 
anti-angiogenic factors, such as angiostatin and 
tumstatin3,34 %7 !"#  & 
as an essential molecule for angiogenesis both in 
pathologic and physiologic conditions25,34.
Studies about the expression of MMP-9 in 
periapical lesions are scarce1,5 and their results 
suggest that MMP-9 might play a role in the 
extracellular matrix destruction associated with 
the development/progression of these lesions5. 
Moreover, according to Belmar, et al.1 (2008), MMP-
9 could represent a useful marker in monitoring 
chronic periapical periodontitis in gingival crevicular 
fluid. To our knowledge, there are no studies 
evaluating the participation of MMP-9 in the 
angiogenesis on RCs and RRCs.
A high percentage of RCs evaluated in this 
study showed strong expression of MMP-9 in the 
endothelial cells, whereas the RRCs exhibited 
a tendency for a weaker expression of this 
protease. In addition, despite the absence of 
statistical significance (p>0.05), most lesions 
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expression of MMP-9, whereas a high proportion 
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revealed strong expression of this protease.
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and macrophages, are able to produce a series of 
angiogenic factors, such as platelet derived growth 
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
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tumor necrosis factor-alpha (TNF-) and VEGF27. 
TNF-a is known to stimulate secretion of MMP-9 
in microvascular endothelial cells20. In addition, 
studies have reported a positive correlation between 
VEGF and MMP-912,17. Coherently, Lee, et al.15 (2006) 
analyzed the expression of VEGF and MMP-9 in 
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down-regulates the expression of MMP-9.
Jurisic, et al.13 (2008) showed a positive 
correlation between the concentration of TNF-
%&
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
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agreement with the present study, Nonaka, et al.26 
(2008) observed a lower number of immunopositive 
cells for VEGF in periapical lesions with few 
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MMP-9 in endothelial cells of RCs and RRCs might be 
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in these lesions, a fact that could also explain the 
tendency for a weaker expression of this protease 
in RRCs.
In addition to the synthesis of proangiogenic 
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with angiogenesis through secretion of MMP-9. 
Studies about carcinogenesis in mouse models 
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from matrix stores constitutes an important event 
during tumor angiogenesis9,28. This mobilization was 
 
!"#$'	 
 
	
cells, particularly macrophages and neutrophils9,28. 
According to Mott and Werb23 (2004), although 
these are tumor models, it is highly likely that 
similar mechanisms for the release of VEGF occur 
in non-pathological conditions. Data obtained from 
the study of Carneiro, et al.5 (2009) suggests the 
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macrophages, in the MMP-9 expression in apical 
periodontitis lesions. Thus, it could be hypothesized 
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
!"#&	 
	$ 
RCs and RRCs might contribute with angiogenesis 
through mobilization of VEGF from the matrix 
stores, making it more available to VEGF receptors. 
Accordingly, VEGF has been recognized as a 
bioactive substrate for MMP-92,29.
In the present study, lesions with strong 
expression of MMP-9 in endothelial cells showed 
both a larger number of immunopositive cells 
for VEGF (p<0.05) and a higher MVC (p<0.05). 
It could also be observed a positive correlation 
between the expression of MMP-9 and both the 
number of immunopositive cells for VEGF (p<0.05) 
and the angiogenic index (p<0.05). These results 
agree with the positive correlation between VEGF 
and MMP-9 reported in the literature12,17. Hollborn, 
et al.12 (2007) observed that MMP-9 causes 
the upregulation of VEGF expression in retinal 
pigmented cells. In face of their findings, the 
authors suggested that MMP-9 also may facilitate 
pathologic neovascularization through stimulation 
of the production of angiogenic factors.
According to Li, et al.17 (2006), angiogenesis 
is a process that not only needs several vascular 
growth factors, but also requires degradation of 
vascular basement membrane and remodeling 
of the extracellular matrix to enable endothelial 
cells to migrate into surrounding tissues. Thus, 
the present results suggest that MMP-9 might be 
an important molecule for angiogenesis in RCs 
and RRCs, probably promoting degradation of 
components of vascular basement membrane3, and 
thereby allowing proteolysis-associated migration 
of endothelial cells12,14.
CONCLUSIONS
In conclusion, our results suggest an important 
role for VEGF and MMP-9 in the angiogenesis on 
RCs and RRCs. In these lesions, the expression of 
these molecules and the MVC is closely related to 
 	 
  
	  
expression of VEGF in the epithelial lining of RCs 
and RRCs might be important for the enlargement 
of these lesions.
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